Methods and compositions related to triple-negative breast cancer
Abstract:
Embodiments are directed to kits and methods of treating a breast cancer patient with a glucocorticoid receptor antagonist with or without an anticancer agent or compound after the patient has been determined to be susceptible to treatment with the glucocorticoid receptor antagonist.
Public/Granted literature
Information query
Patent Agency Ranking
0/0